-
1.发明公开ORAL PHARMACEUTICAL FORMULATIONS COMPRISING ACID-LABILE ACTIVE INGREDIENTS AND A WATER-SOLUBLE SUGAR DERIVATE, USE THEREOF AND THE SUITABLE PROCESS FOR MANUFACTURING THESE 审中-公开口服药物制剂酸不稳定剂和生产过程中的水溶性衍生物，使用及SUITABLE
公开(公告)号：EP1617842A1
公开(公告)日：2006-01-25
申请号：EP04760093.7
申请日：2004-04-22
发明人： KOLHE, Ujwal, Damu , KRISHNA, Divi, Murali , DIXIT, Akhilesh, Ashok , DESHMUKH, Abhijit, Mukund , RAJPUT, Narayan, Daga , MOHAN, Mailatur, Sivaraman , REDDY, Manne, Satyanarayana , KUMAR, Muppa, Kishore , PURENDER, Koilkonda , REDDY, Alieti, Sanjay
IPC分类号： A61K31/4439 , A61K9/20 , A61K9/28 , A61K9/48 , A61P1/04
CPC分类号： A61K9/2886 , A61K9/2018 , A61K9/2846 , A61K31/4439
摘要： An oral pharmaceutical formulation in dosage form comprising and acid-labile compound, a water-soluble sugar and optionally organic base, use of that formulation for the manufacture of a medicament to inhibit gastric secretion and a process for the production are described.
-
2.发明授权
公开(公告)号：EP1515963B1
公开(公告)日：2007-02-14
申请号：EP03762106.7
申请日：2003-06-27
发明人： REDDY, Manne, Satyanarayana , KUMAR, Muppa, Kishore , REDDY, Kikkuru, Srirami , PURANDHAR, Koilkonda , SREENATH, Keshaboina
IPC分类号： C07D401/12 , A61K31/44 , A61P1/04
CPC分类号： C07D401/12
摘要： A process of preparation of optically pure or optically enriched isomers of omeprazole and structurally related sulfoxides is provided. Also provided are an amorphous form of esomeprazole, as well a pharmaceutical composition containing it and a method of using it for treatment of gastric disorders.
-
3.发明公开
公开(公告)号：EP1515963A2
公开(公告)日：2005-03-23
申请号：EP03762106.7
申请日：2003-06-27
发明人： REDDY, Manne, Satyanarayana , KUMAR, Muppa, Kishore , REDDY, Kikkuru, Srirami , PURANDHAR, Koilkonda , SREENATH, Keshaboina
IPC分类号： C07D401/12 , A61K31/44 , A61P1/04
CPC分类号： C07D401/12
摘要： A process of preparation of optically pure or optically enriched isomers of omeprazole and structurally related sulfoxides is provided. Also provided are an amorphous form of esomeprazole, as well a pharmaceutical composition containing it and a method of using it for treatment of gastric disorders.
-
4.发明授权ANHYDROUS CRYSTALLINE FORMS I AND II OF 1-CYCLOPROPYL-6-FLUORO-8-METHOXY-7-(3-METHYL-1-PIPERAZINYL) 4-OXO-1, 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID (GATIFLOXACIN) 有权无水结晶形式I和II的1-环丙基-6-氟-8-甲氧基-7-（3-甲基-1-哌嗪基）-4-氧代-1,4-二氢喹啉-3-羧酸（加替沙星）
公开(公告)号：EP1492535B1
公开(公告)日：2005-10-26
申请号：EP03723931.6
申请日：2003-04-07
发明人： REDDY, Manne, Satyanarayana , RAJU, Chakilam, Naga , RAJU, Vetukuri, Venkata, Naga, Kali, vara, Prasada , REDDY, Ningam, Srinivas , KUMAR, rapolu, Rajesh
IPC分类号： A61K31/496 , C07D215/56
CPC分类号： C07D215/56
摘要： The present invention relates to the novel anhydrous crystalline forms I and II of 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl) 4-oxo-l, 4-dihydroquinoline-3-carboxylic acid (gatifloxacin) which can be depicted as Formula (I). The present invention also relates to methods of making the anhydrous Forms I and II of Gatifloxacin, use of the forms and methods for preparing them.
-
5.发明公开ANHYDROUS CRYSTALLINE FORMS I AND II OF 1-CYCLOPROPYL-6-FLUORO-8-METHOXY-7-(3-METHYL-1-PIPERAZINYL) 4-OXO-1, 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID (GATIFLOXACIN) 有权1-环丙基-6-氟-8-甲氧基-7-（3-甲基-1-哌嗪基）-4-氧-1,4-二氢喹啉-3-羧酸（全氟氧杂环己烯）的无水结晶形式I和II
公开(公告)号：EP1492535A1
公开(公告)日：2005-01-05
申请号：EP03723931.6
申请日：2003-04-07
发明人： REDDY, Manne, Satyanarayana , RAJU, Chakilam, Naga , RAJU, Vetukuri, Venkata, Naga, Kali, vara, Prasada , REDDY, Ningam, Srinivas , KUMAR, rapolu, Rajesh
IPC分类号： A61K31/496 , C07D215/56
CPC分类号： C07D215/56
摘要： The present invention relates to the novel anhydrous crystalline forms I and II of 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl) 4-oxo-l, 4-dihydroquinoline-3-carboxylic acid (gatifloxacin) which can be depicted as Formula (I). The present invention also relates to methods of making the anhydrous Forms I and II of Gatifloxacin, use of the forms and methods for preparing them.
摘要翻译： 本发明涉及1-环丙基-6-氟-8-甲氧基-7-（3-甲基-1-哌嗪基）-4-氧代-1,4-二氢喹啉-3-羧酸的新型无水晶型I和II 酸（加替沙星），其可以描述为式（I）。 本发明还涉及制备加替沙星的无水形式I和II的方法，使用这些形式和制备它们的方法。
-
公开(公告)号：EP1487820A1
公开(公告)日：2004-12-22
申请号：EP03721471.5
申请日：2003-03-25
发明人： REDDY, Manne, Satyanarayana , ESWARAIAH, Sajja , BOLUGODDU, Vijaya, Bhaskar , PINGILI, Ramchandra, Reddy , GANTA, Madhusudhan, Reddy
IPC分类号： C07D401/12
CPC分类号： C07D401/12
摘要： The present invention relates to novel polymorphic forms of Rabeprazole sodium. The present invention also relates to methods of making polymorphic forms of Rabeprazole sodium. Achiphex7 (Rabeprazole sodium) is an inhibitor of the gastric proton pump. It causes dose-dependant inhibition of acid secretion and is useful as an antiulcer agent. The chemical designation of Rabeprazole sodium is 2-[[[4-(3-methoxypropoxy)-3 methyl-2-pyridinyl]-methyl] sulfinyl]-1H-benzimidazole sodium. It may be represented by Formula (1).
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.013 秒)
